Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Sun Pharmaceutical Industries Ltd.
  6. News
  7. Summary
    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
Delayed Quote. Delayed NSE India Stock Exchange - 01/17 06:16:45 am
853.2 INR   -0.76%
01/13Indian Benchmarks Extend Gains on Thursday; Tata Steel Jumps 6%
MT
01/04Indian Indices Extend Gains on Tuesday; NTPC Jumps 6%
MT
2021Sun Pharma receives DCGI approval for Molxvir (Molnupiravir) in India
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sun Pharmaceutical to Likely Launch COVID-19 Treatment Drug Molxvir in India

11/11/2021 | 07:08pm EST


ę MT Newswires 2021
All news about SUN PHARMACEUTICAL INDUSTRIES LTD.
01/13Indian Benchmarks Extend Gains on Thursday; Tata Steel Jumps 6%
MT
01/04Indian Indices Extend Gains on Tuesday; NTPC Jumps 6%
MT
2021Sun Pharma receives DCGI approval for Molxvir (Molnupiravir) in India
AQ
2021Indian Indices Close in Red Midweek; Eicher Motors Climbs 3%
MT
2021Sun Pharmaceutical Industries to Set Up Manufacturing Facility in Andhra Pradesh, India
MT
2021Indian Indices Extend Gains on Tuesday; Asian Paints Climbs 3%
MT
2021Indian shares end higher on upbeat global cues; tech, auto stocks jump
RE
2021Sun Pharmaceutical Industries Gets Emergency Use Authorization to Sell Generic Molnupir..
MT
2021Sun Pharma Receives DCGI Approval for Molxvir« (Molnupiravir) in India
CI
2021Sun Pharma Announces US FDA Approval for Generic Amphotericin B Liposome Injection
AQ
More news
Analyst Recommendations on SUN PHARMACEUTICAL INDUSTRIES LTD.
More recommendations
Financials
Sales 2022 384 B 5 165 M 5 165 M
Net income 2022 70 404 M 948 M 948 M
Net cash 2022 93 082 M 1 254 M 1 254 M
P/E ratio 2022 28,5x
Yield 2022 0,61%
Capitalization 2 047 B 27 558 M 27 568 M
EV / Sales 2022 5,09x
EV / Sales 2023 4,51x
Nbr of Employees 37 000
Free-Float -
Chart SUN PHARMACEUTICAL INDUSTRIES LTD.
Duration : Period :
Sun Pharmaceutical Industries Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SUN PHARMACEUTICAL INDUSTRIES LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 33
Last Close Price 853,20 INR
Average target price 922,33 INR
Spread / Average Target 8,10%
EPS Revisions
Managers and Directors
Dilip Shantilal Shanghvi Managing Director & Executive Director
C. S. Muralidharan Chief Financial Officer
Israel Makov Non-Executive Chairman
Atanu Roy SVP & Chief Information Officer
Davinder Singh Executive Vice President-Global Operations